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Background
Glioblastoma (GBM), one of the most malignant human
neoplasms, responds poorly to current treatment modal-
ities, being temozolomide (TMZ) the mostly used drug
for treatment. Tetra-O-methyl Nordihydroguaiaretic
Acid (M4N) is a global transcriptional repressor of genes
dependent of Sp1 transcription factors, such as Survivin
and CDK1. We evaluated expression of Survivin and
CDK1 in glioblastoma and analyzed the effects of M4N
combined or not with temozolomide and radiation on
cell lines and primary cultures of GBM.
Materials and methods
RT-PCR assays were performed to determinate survivin-
spliced variants and CDK1 mRNA expression in glioblas-
toma tumor samples and cell lines. Cell proliferation was
measured by XTT assay, and cell cycle and apoptosis
were determined by flow cytometry. Drug combination
analyzes using different schedules of administration
(simultaneous and sequential) were made based in Chou-
Talalay method on GBM cell lines and primary cultures.
Gamma radiation for clonogenic survival used the doses
of 2, 4, and 6 Gy.
Results
All survivin-spliced variants and CDK1 gene were expressed
in GBM samples (n=16) and cell lines (n=6), except the
survivin-2B variant that was expressed exclusively in GBM
cell lines. M4N decreased cell proliferation separately and
synergistically with TMZ, besides enhancement of radiation
effects, mainly when associated with TMZ. M4N also
induced apoptotic cell death, decreased mitotic index and
arrested the cell cycle in G2/M phase. M4N treatment
down-regulated CDK1 gene and survivin and survivin-
ΔEx3 variants, while the survivin-2B variant was up-
regulated.
Conclusions
Our results suggest a potential clinical application of
M4N in combination with TMZ in GB treatment.
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